An adult patient with pulmonary arterial hypertension (PAH) and metastatic lung adenocarcinoma showed significant clinical improvement when chemotherapy and immunotherapy were added to PAH triple therapy. Chemotherapy and immunotherapy in conjunction with triple therapy may influence the efficacy of pulmonary arterial hypertension (PAH) treatment and improve clinical status, according to...